Birdwatch Note
2023-03-21 01:22:44 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Emergent Biosolutions "Emergent disputes the claim that 400 million doses of vaccine were rendered unusable. It is very difficult to estimate dose equivalents for batches that do not complete the manufacturing process or leave the facility to be turned into vaccine" https://www.emergentbiosolutions.com/media-statement/emergent-response-to-new-congressional-report/
Written by E70A3BC01125A83A1FE256833E9EC0C5D9BDC229052654B84AF7BEF40903C6DA
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1637902229385494533
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1637988077548216321
- noteId - 1637988077548216321
- participantId -
- noteAuthorParticipantId - E70A3BC01125A83A1FE256833E9EC0C5D9BDC229052654B84AF7BEF40903C6DA Participant Details
- createdAtMillis - 1679361764692
- tweetId - 1637902229385494533
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Emergent Biosolutions "Emergent disputes the claim that 400 million doses of vaccine were rendered unusable. It is very difficult to estimate dose equivalents for batches that do not complete the manufacturing process or leave the facility to be turned into vaccine" https://www.emergentbiosolutions.com/media-statement/emergent-response-to-new-congressional-report/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-03-21 01:22:44 UTC (1679361764692) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-22 02:38:34 UTC (1679452714982) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-03-21 06:25:53 -0500 | Rating Details | |
2023-03-21 00:32:34 -0500 | Rating Details | |
2023-03-20 23:49:45 -0500 | Rating Details | |
2023-03-20 23:49:20 -0500 | Rating Details | |
2023-03-20 23:49:14 -0500 | Rating Details | |
2023-03-20 23:38:06 -0500 | Rating Details | |
2023-03-20 21:54:26 -0500 | Rating Details | |
2023-03-20 21:36:56 -0500 | Rating Details | |
2023-03-20 21:31:08 -0500 | Rating Details | |
2023-03-20 21:30:58 -0500 | Rating Details | |
2023-03-20 21:24:30 -0500 | Rating Details | |
2023-03-20 21:16:16 -0500 | Rating Details | |
2023-03-20 21:15:05 -0500 | Rating Details | |
2023-03-20 21:11:55 -0500 | Rating Details | |
2023-03-20 21:08:56 -0500 | Rating Details | |
2023-03-20 20:53:31 -0500 | Rating Details | |
2023-03-20 20:53:18 -0500 | Rating Details | |
2023-03-20 20:49:39 -0500 | Rating Details | |
2023-03-20 23:49:14 -0500 | Rating Details | |
2023-03-20 20:53:18 -0500 | Rating Details | |
2023-03-20 21:54:26 -0500 | Rating Details | |
2023-03-20 21:30:58 -0500 | Rating Details | |
2023-03-20 23:49:20 -0500 | Rating Details | |
2023-03-20 20:53:31 -0500 | Rating Details | |
2023-03-20 21:15:05 -0500 | Rating Details | |
2023-03-20 21:08:56 -0500 | Rating Details | |
2023-03-20 21:36:56 -0500 | Rating Details | |
2023-03-21 00:32:34 -0500 | Rating Details | |
2023-03-20 21:31:08 -0500 | Rating Details | |
2023-03-20 21:24:30 -0500 | Rating Details | |
2023-03-20 23:49:45 -0500 | Rating Details | |
2023-03-20 23:38:06 -0500 | Rating Details | |
2023-03-21 06:25:53 -0500 | Rating Details | |
2023-03-20 21:16:16 -0500 | Rating Details | |
2023-03-20 21:11:55 -0500 | Rating Details | |
2023-03-20 20:49:39 -0500 | Rating Details |